← Leaderboards
Hazel H Szeto
Weill Medical College Of Cornell Univ
$8,842,007
Attributed
$8,842,007
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$15,304,514 · 14
By mechanism
P01$11,465,322 · 10
R37$1,696,654 · 1
T32$1,255,960 · 1
R01$498,078 · 1
R21$388,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Peter W Schiller$3,886,349
- Dominic M Desiderio$3,768,562
Others in their field
Top investigators on “Peptide Analog”
- Norman Wolmark · Nsabp Foundation, Inc.$52,338,276
- David Heimbrook · Leidos Biomedical Research, Inc.$26,054,235
- Richard Douglas Moore · Johns Hopkins University$13,632,642
- Jane V Aldrich · University Of Maryland Baltimore$12,324,818
- Jean E Rivier · Salk Institute For Biological Studies$11,711,552
- Michael Lafleur · Arietis$9,918,442
Research focus
Peptide AnalogAnalgesicsEndogenous OpioidSheepPharmacokineticsObstetric AnesthesiaOpioid ReceptorPeptidesHeart RateDrug Adverse EffectEmbryo /Fetus Drug Adverse EffectDrug MetabolismMitochondriaSynthetic PeptidePreventIn VivoOxidative StressProgramsAgedElectron TransportElectronsAnalogDynorphinsAging
Grant awards (43)
Project 3 - Mitochondrial ROS in aging vision and retina$368,684
P01 · FY2020 · AG · contact PI
Core D: Mitochondrial Structure & Function$242,780
P01 · FY2020 · AG · contact PI
Project 3 - Mitochondrial ROS in aging vision and retina$368,684
P01 · FY2019 · AG · contact PI
Core D: Mitochondrial Structure & Function$242,780
P01 · FY2019 · AG · contact PI
Project 3 - Mitochondrial ROS in aging vision and retina$388,316
P01 · FY2018 · AG · contact PI
Core D: Mitochondrial Structure & Function$262,413
P01 · FY2018 · AG · contact PI
Project 3 - Mitochondrial ROS in aging vision and retina$383,275
P01 · FY2017 · AG · contact PI
Core D: Mitochondrial Structure & Function$257,373
P01 · FY2017 · AG · contact PI
Pharmacology and Neuroscience of Drug Abuse$374,527
T32 · FY2011 · DA · contact PI
MITOCHONDRIAL PROTECTIVE CHEMISTRY$185,939
P01 · FY2011 · AG · contact PI
Pharmacology and Neuroscience of Drug Abuse$445,570
T32 · FY2010 · DA · contact PI
Pharmacology and Neuroscience of Drug Abuse$435,863
T32 · FY2009 · DA · contact PI
SYSTEMICALLY-ACTIVE OPIOID PEPTIDE ANALOGS$870,062
P01 · FY2007 · DA · contact PI
PROJECT # 3 - PHARAMCOLOGY PROJECT$284,893
P01 · FY2007 · DA · contact PI
PROJECT #2 - PHARMACOKINETICS PROJECT$225,439
P01 · FY2007 · DA · contact PI
Core A - Administrative Core$28,527
P01 · FY2007 · DA · contact PI
SYSTEMICALLY-ACTIVE OPIOID PEPTIDE ANALOGS$872,999
P01 · FY2006 · DA · contact PI
Mitoprotective and antioxidant peptides for DM treatment$246,078
R01 · FY2006 · DK · contact PI
SYSTEMICALLY-ACTIVE OPIOID PEPTIDE ANALOGS$871,088
P01 · FY2005 · DA
Mitoprotective and antioxidant peptides for DM treatment$252,000
R01 · FY2005 · DK
Cell-Permeable Peptides for Mitochondrial Protection$194,250
R21 · FY2005 · NS
SYSTEMICALLY-ACTIVE OPIOID PEPTIDE ANALOGS$848,842
P01 · FY2004 · DA
Cell-Permeable Peptides for Mitochondrial Protection$194,250
R21 · FY2004 · NS
SYSTEMICALLY-ACTIVE OPIOID PEPTIDE ANALOGS$936,577
P01 · FY2003 · DA
SYSTEMICALLY-ACTIVE OPIOID PEPTIDE ANALOGS$127,977
P01 · FY2003 · DA
PHARMACOKINETICS AND FETAL EXPOSURE TO NARCOTICS$593,311
R37 · FY2002 · DA
OPIOID PEPTIDE ANALOGS AS OBSTETRIC ANALGESICS$592,910
P01 · FY2002 · DA
MECHANISMS OF ACTION$180,664
P01 · FY2002 · DA
MATERNAL/FETAL PHARMACOKINETICS AND PHARMACODYNAMICS$180,664
P01 · FY2002 · DA
OPIOID PEPTIDE ANALOGS AS OBSTETRIC ANALGESICS$633,895
P01 · FY2001 · DA
PHARMACOKINETICS AND FETAL EXPOSURE TO NARCOTICS$514,140
R37 · FY2001 · DA
MECHANISMS OF ACTION$180,664
P01 · FY2001 · DA
MATERNAL/FETAL PHARMACOKINETICS AND PHARMACODYNAMICS$180,664
P01 · FY2001 · DA
PHARMACOKINETICS AND FETAL EXPOSURE TO NARCOTICS$85,783
R37 · FY2001 · DA
Non-opioid Actions of Dynorphin A in Anterior Pituitary$0
P01 · FY2001 · DA
OPIOID PEPTIDE ANALOGS AS OBSTETRIC ANALGESICS$688,157
P01 · FY2000 · DA
PHARMACOKINETICS AND FETAL EXPOSURE TO NARCOTICS$503,420
R37 · FY2000 · DA
MATERNAL/FETAL PHARMACOKINETICS AND PHARMACODYNAMICS$277,791
P01 · FY2000 · DA
MECHANISMS OF ACTION$277,791
P01 · FY2000 · DA
MECHANISMS OF ACTION$180,664
P01 · FY2000 · DA
MATERNAL/FETAL PHARMACOKINETICS AND PHARMACODYNAMICS$180,664
P01 · FY2000 · DA
Non-opioid Actions of Dynorphin A in Anterior Pituitary$124,146
P01 · FY2000 · DA
OPIOID PEPTIDE ANALOGS AS OBSTETRIC ANALGESICS$20,000
P01 · FY2000 · DA